Can Drugs Be Absorbed Through the Skin?

Drugs absolutely can be absorbed through the skin, and this happens both intentionally and by accident every day. Nicotine patches, hormone gels, and pain-relief creams all rely on the skin’s ability to let molecules pass into the bloodstream. But the skin is also the body’s primary physical barrier against the outside world, which means getting a drug through it is far harder than swallowing a pill. The interplay between what the skin lets in and what it keeps out shapes everything from how medications are designed to how hazardous chemicals cause harm.

Why Skin Is Such an Effective Barrier

The outermost layer of your skin, called the stratum corneum, is the main gatekeeper. It is only about 10 to 20 micrometers thick, yet it blocks the vast majority of substances from reaching the living tissue underneath. Its structure is often compared to a brick wall: flat, dead skin cells (the “bricks”) are held together by tightly organized layers of fatty molecules (the “mortar”).¹ This dense, lipid-rich arrangement is what makes skin so good at keeping water in and foreign substances out.

Beneath the stratum corneum sit the living layers of the epidermis and the dermis, which is packed with blood vessels. Once a molecule crosses the stratum corneum and reaches those blood vessels, it enters the systemic circulation and can affect the entire body. The challenge for any drug trying to reach the bloodstream through the skin is almost entirely about getting past that thin but formidable outer layer.

Three Routes a Drug Can Take

Molecules don’t all sneak through the skin the same way. Researchers describe three main pathways through the stratum corneum.² The first, and most common for small drug molecules, is the intercellular route, where a substance weaves through the fatty “mortar” between skin cells. The second is the transcellular route, where a molecule passes directly through the skin cells themselves. This is harder because each cell’s interior is watery while the surrounding lipid layers are oily, so the molecule has to keep switching between environments that favor different chemical properties.

The third route bypasses the stratum corneum altogether. Hair follicles and sweat glands create tiny openings that punch through the barrier. This appendageal route covers a small fraction of total skin area, but it can be a surprisingly effective shortcut for larger molecules or charged particles that would otherwise have no hope of crossing the lipid-packed stratum corneum.

What Makes a Drug Good or Bad at Crossing Skin

Not every drug can be delivered through the skin. The molecule’s size, its preference for fat versus water, and its overall charge all play decisive roles.³ As a rough guide, small molecules that are moderately fat-loving tend to cross the stratum corneum most easily. They dissolve into the lipid mortar and diffuse through. Very large molecules, highly water-soluble molecules, and electrically charged molecules have a much harder time.

This is why transdermal patches work well for drugs like nicotine, fentanyl, and estradiol. These are all relatively small, lipophilic molecules that naturally want to move into the skin’s fatty layers. Insulin, by contrast, is a large protein that cannot cross the skin barrier on its own, which is why people with diabetes still rely on injections or pumps rather than a simple patch.

The vehicle carrying the drug matters too. A drug dissolved in an alcohol-based gel will interact with the skin differently than the same drug in a thick ointment. Temperature and hydration of the skin also shift absorption rates. Higher humidity can boost absorption of water-loving compounds by increasing the water content in the stratum corneum.⁴ One mechanism behind this is dew condensation on the skin surface under high-humidity conditions, which draws more water into the barrier and opens it up to hydrophilic molecules. Fat-soluble drugs are less affected by humidity changes.

Where on the Body Absorption Happens Fastest

Your skin is not equally permeable everywhere. The forehead, scalp, neck, and genital area absorb chemicals much more readily than the trunk, back, or thighs.⁵ Several factors explain the difference. Skin thickness varies, hair follicle density varies, and blood flow to different regions varies. The palms and soles, despite being heavily used, are among the least permeable spots on the body because their stratum corneum is extraordinarily thick.

These regional differences have real practical consequences. A steroid cream applied behind the ear or on the eyelids produces a far stronger effect than the same cream rubbed onto the shin. Pharmacists and dermatologists choose different potencies for different body sites partly because of absorption differences. And in occupational safety, exposure guidelines account for which body parts come into contact with a hazardous substance, not just the total skin area involved.

Why Babies, Children, and People With Skin Conditions Absorb More

Age changes the equation significantly. Newborns, especially premature infants, have a poorly developed epidermis that is far more permeable than adult skin. In very premature babies during the early weeks of life, the skin barrier is thin enough that topically applied agents can be absorbed at dangerous levels, sometimes causing toxic systemic effects without anyone initially recognizing the cause.⁶ Even in full-term infants and young children, the skin is thinner and the ratio of skin surface area to body weight is much higher than in adults, which means a given amount of absorbed chemical produces a proportionally larger dose. This is one reason why children are more susceptible to systemic side effects from topical corticosteroids.⁷

Skin disease also dramatically changes permeability. A systematic review examining skin absorption in people with atopic dermatitis (the most common form of eczema) found that these patients had roughly double the skin absorption compared to healthy controls.⁸ The barrier impairment exists in both visibly affected skin and skin that appears normal, which means the increased absorption is not limited to the red, inflamed patches. People with eczema are typically applying emollients and topical medications daily, so this heightened permeability raises their lifetime exposure to the chemical ingredients in those products.

Psoriasis follows a similar pattern. During active disease, the skin barrier breaks down and permeability increases, though the relationship is not perfectly linear. Research using psoriatic skin models has shown that absorption rises as the disease progresses but can plateau or even partially reverse in advanced stages, likely because of the thick, scaly plaques that build up and paradoxically create a new physical barrier of their own.⁹

Technologies That Push Drugs Through the Barrier

Because the stratum corneum blocks so many useful drugs, researchers have spent decades developing ways to get around it. The simplest approach uses chemical penetration enhancers, substances mixed into a cream or patch formulation that temporarily loosen the skin’s lipid structure. These enhancers work through several mechanisms, including disrupting the organized lipid layers, altering the protein structure of skin cells, or helping the drug dissolve into the stratum corneum more readily.¹⁰ Alcohols, fatty acids, and certain surfactants are common examples. The goal is always to boost permeation without permanently damaging the skin, so that the barrier recovers once the product is removed.

One example of how this plays out in drug development: a transdermal patch for riluzole, a medication used for amyotrophic lateral sclerosis (ALS), uses a specific enhancer that both helps the drug release from the adhesive and increases the fluidity of skin lipids, letting more drug cross through.¹¹ The ability to deliver a steady dose of riluzole through the skin, rather than requiring multiple daily pills, would be a meaningful quality-of-life improvement for people with a progressive neurological disease.

Physical methods take a more aggressive approach to the barrier. Microneedles are tiny needles, often shorter than a millimeter, that create microchannels through the stratum corneum and deliver drugs into the deeper skin layers without reaching the nerve endings that make traditional injections painful.¹² Some microneedle patches dissolve in the skin, releasing their drug payload as they go. Others are coated with drug that washes off into the channels. The technology is being explored for everything from vaccine delivery to weight management medications.

Iontophoresis uses a mild electric current to drive charged drug molecules through the skin.¹³ A small battery-powered device sends the current from a patch containing the drug into the skin, pushing ionic molecules in the direction of the current. It works for both charged and uncharged molecules and has shown particular promise for treating inflammatory skin conditions, where delivering anti-inflammatory drugs directly into the affected area can be more effective and produce fewer systemic side effects than oral medication.¹⁴

Sonophoresis uses ultrasound waves, typically at low frequencies, to temporarily disrupt the stratum corneum. The mechanism centers on cavitation: the sound waves create tiny gas bubbles in the coupling medium on the skin surface, and when those bubbles collapse, they generate enough force to open pathways through the barrier.¹⁵

Nanoparticles and Lipid Carriers

Another frontier involves packaging drugs inside nanoscale lipid particles. Solid lipid nanoparticles and nanostructured lipid carriers are tiny fat-based capsules that can improve how a drug dissolves, how it interacts with skin lipids, and how steadily it releases over time. These carriers stick to the skin surface, create an occlusive film that hydrates the stratum corneum, and can fluidize the barrier lipids to improve penetration.¹⁶ Because they are made from biocompatible fats, they tend to be well tolerated and are being studied for delivering everything from anti-aging compounds to anti-cancer drugs directly into skin lesions.

Accidental Absorption and Toxic Exposure

The same permeability that makes transdermal therapy possible also creates risks. Pesticides, industrial solvents, and certain drugs can be absorbed through occupational or accidental skin contact, sometimes causing serious systemic toxicity.¹⁷ Farmworkers exposed to organophosphate pesticides, mechanics handling certain solvents, and healthcare workers in contact with chemotherapy drugs all face real dermal absorption hazards.

Fentanyl is a drug that has drawn particular public concern about skin absorption. While fentanyl can penetrate the skin, and therapeutic patches exploit this, the rate of penetration through intact skin is slow. Research on human skin exposure to fentanyl has assessed the risk of accidental intoxication through brief dermal contact as low, because the drug simply does not cross intact skin fast enough to reach dangerous blood levels from a casual touch.¹⁸ Therapeutic fentanyl patches, by contrast, are designed to maintain prolonged contact over many hours with chemical enhancers in the formulation that boost absorption to clinically useful rates.¹⁹ The difference between accidental contact and a 72-hour engineered patch illustrates why the details of formulation, duration, and skin condition matter so much in determining whether absorption is trivial or clinically significant.

That said, damaged skin changes the picture. Cuts, abrasions, burns, or chemical damage to the stratum corneum remove or weaken the primary barrier, and substances that would be stopped by intact skin can then reach the bloodstream quickly. This is why decontamination protocols for chemical exposure always stress getting the substance off the skin as rapidly as possible, before the barrier has time to be compromised further.

The Skin Has Its Own Metabolism

One fact that surprises many people is that the skin is not just a passive membrane. It contains enzymes that can chemically modify drugs as they pass through. The skin has esterases, cytochrome P450 enzymes, and other metabolic machinery, concentrated most heavily around the junction between the epidermis and dermis.²⁰ When methyl salicylate (the active ingredient in many muscle rubs) crosses the skin, for example, esterases in the dermis break it down into salicylic acid before it even reaches the bloodstream.

This cutaneous metabolism is both a feature and a complication. For some prodrugs, the skin’s enzymes activate the drug right where it is needed. For others, premature metabolism can degrade the drug before enough reaches systemic circulation. It also means that one of the commonly cited advantages of transdermal delivery, bypassing liver first-pass metabolism, comes with a caveat: the skin performs its own, smaller-scale version of the same process. The degree of skin metabolism varies between individuals and between body sites, adding yet another variable to an already complex picture.

Vaccines Delivered Through the Skin

The skin is not just a route for delivering drugs into the bloodstream. It is itself a highly immunologically active organ, packed with specialized immune cells. This has led to growing interest in transcutaneous immunization, where vaccine antigens are applied directly to the skin surface rather than injected. Early human studies demonstrated that a simple patch containing a bacterial toxin could produce strong antibody responses, establishing that needle-free vaccination through the skin is feasible.²¹

The appeal is obvious. Patches don’t require trained medical personnel to administer, they eliminate needle-related injuries and infections, and they are easier to store and distribute in resource-limited settings. The challenge is that most vaccine antigens are large proteins or killed pathogens, far too big to cross the stratum corneum on their own. This is where microneedle technology and chemical enhancers converge with immunology. By creating temporary channels in the skin or lightly disrupting the barrier to allow antigens access to the immune cells just below, researchers are trying to combine the convenience of a bandage with the immune response of a traditional shot. Several microneedle-based vaccine patches have reached clinical trials for influenza and other diseases, though none has yet become standard practice.

How Researchers Test Skin Absorption

Understanding skin absorption requires testing, and the methods used shape how confident we can be in the findings. The gold standard is excised human skin mounted in a specialized device called a Franz diffusion cell, where a drug is applied to one side and researchers measure how much crosses to the other over time. However, human skin is in limited supply, and ethical concerns around animal testing have pushed the field toward synthetic membranes and lab-grown skin models.²² European regulators have established guidelines specifying which skin sources and experimental setups are acceptable for permeation studies.

Animal skin, particularly pig skin, has long been used as a stand-in for human skin because its structure is broadly similar, but the correlation is imperfect. Studies in beagle dogs have shown that features like hair follicle density and blood vessel distribution vary substantially across body sites, affecting drug penetration in ways that may not perfectly mirror the human situation.²³ The push toward organ-on-a-chip models and 3D-printed skin constructs reflects an effort to get more reliable, human-relevant data without depending on donated tissue or animal experiments. These newer models are improving but have not yet fully replicated the complexity of living human skin with its variable thickness, blood flow, and metabolic activity.

For anyone curious about their own exposure to topical products, the practical takeaway from all this research is that your skin does absorb what you put on it, but usually in small amounts and slowly. The dose reaching your bloodstream from a lotion or sunscreen is typically a tiny fraction of what you would get from swallowing the same ingredient. Where the situation changes is when formulations are specifically designed to enhance absorption, when the skin is damaged or diseased, when the person is very young, or when contact is prolonged over large surface areas. Under any of those conditions, skin absorption moves from a footnote to a clinically meaningful route of drug or chemical entry into the body.